Allergy Therapeutics(GB:AGY)
GBX 1.490.00 (0.00%)
GB:AGY
Allergy Therapeutics financials statements
GBX 1.49
At close:0.00 (0.00%)
Want to see GB:AGY full AI Analyst Report?
Allergy Therapeutics (AGY) Income Statement
17 Followers
Allergy Therapeutics Income Statement
Last quarter (Q2 2026), Allergy Therapeutics's total revenue was £36.28M, an increase of 8.07% from the same quarter last year. In Q2, Allergy Therapeutics's net income was £-19.92M. See Allergy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| £ 55.04M | £ 55.20M | £ 59.59M | £ 72.77M | £ 84.33M | |
| £ 25.13M | £ 29.74M | £ 32.69M | £ 48.95M | £ 61.80M | |
| £ 54.63M | £ 64.99M | £ 72.90M | £ 61.95M | £ 59.16M | |
| Depreciation and Amortization | £ 4.17M | £ 4.32M | £ 4.22M | £ 4.17M | £ 4.13M |
| £ -29.43M | £ -30.74M | £ -36.24M | £ -8.69M | £ 7.61M | |
| £ -29.50M | £ -35.26M | £ -34.85M | £ -13.00M | £ 4.03M | |
| £ -10.94M | £ -3.91M | £ -7.77M | £ -396.00K | £ -374.00K | |
| £ -40.44M | £ -39.17M | £ -42.62M | £ -13.40M | £ 3.66M | |
| £ -40.13M | £ -40.22M | £ -43.07M | £ -13.78M | £ 2.89M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.01 | £ -0.01 | £ -0.06 | £ -0.02 | £ 0.00 |
| Diluted EPS | £ -0.01 | £ -0.01 | £ -0.06 | £ -0.02 | £ 0.00 |
| Weighted Average Shares Outstanding | 4.77B | 3.74B | 669.84M | 642.99M | 671.32M |
| Weighted Average Shares Outstanding (Diluted) | 4.77B | 3.74B | 670.36M | 642.99M | 676.66M |
Currency in GBP
